Table 3.
CIAV Strain | Country | GenBank Accession No. | Genogroup | Reference |
---|---|---|---|---|
Del-Ros | USA | AF313470 | IIIb | N.A. |
26P4 | USA | D10068 | IIIb | [29] |
Nobilis P4 vaccine | The Netherlands | AJ890284 | IIIb | [18] |
Cux-1 | Germany | M55918 | IIIb | [3] |
Cuxhaven 1 | Germany | M81223 | IIIb | [4] |
CAU269-7 | Australia | AF227982 | I | [30] |
3711 | Australia | EF683159 | I | N.A. |
BD-3 | Bangladesh | AF395114 | IIIa | [31] |
CAV/Ibadan.NIE/11.02/100 | Nigeria | AJ888519 | II | [18] |
CAV/Lanlate.NIE/11.02/71 | Nigeria | AJ888528 | IIIa | [18] |
69 | Slovenia | DQ016140 | IIIa | [32] |
98D02152 | USA | AF311892 | IIIb | [33] |
Isolate 4 | Taiwan | KJ728816 | IIIb | N.A. |
Isolate 6 | Taiwan | KJ728817 | IIIb | N.A. |
Isolate 8 | Taiwan | KJ728819 | IIIa | N.A. |
Isolate 9 | Taiwan | KJ728820 | IIIa | N.A. |
CAV-EG-2 | Egypt | MH001553 | IIIb | [34] |
CAV-EG-11 | Egypt | MH001559 | IIIb | [34] |
CAV-EG-13 | Egypt | MH001560 | IIIb | [34] |
CAV-EG-14 | Egypt | MH001565 | II | [34] |
CAV-EG-26 | Egypt | MH001564 | IIIa | [34] |
CAV/LOD5/13 | Poland | KM458172 | IIIa | [35] |
CAV/MPL2/13 | Poland | KM458175 | IIIa | [35] |
CAV/OPL3/13 | Poland | KM458178 | IIIa | [35] |
CAV/SLA3/13 | Poland | KM458182 | IIIa | [35] |
G17.33.3 | Vietnam | MH536104 | IIIa | [36] |
HB1517 | China | KU645516 | IIIa | N.A. |
AH6 | China | DQ124935 | IIIa | N.A. |
HLJ15108 | China | KY486137 | IIIa | [37] |
LF4 | China | AY839944 | IIIb | N.A. |
SD1514 | China | KU645521 | IIIa | N.A. |
704 | Australia | U65414 | II | N.A. |
98D06073 | USA | AF311900 | II | [33] |
1102PT01 | Taiwan | KY888892 | IV | [19] |
1103TN02 | Taiwan | KY888894 | IV | [19] |
SD22 | China | DQ141673 | IV | N.A. |
SD24 | China | AY999018 | IV | N.A. |